Laurion Capital Management »

Bridgebio Pharma shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Bridgebio Pharma shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $16M 19M 0.83
2024-06-30 $15M 19M 0.81
2024-03-31 $16M 19M 0.82
2023-12-31 $16M 19M 0.84
2023-09-30 $15M 19M 0.76
2023-06-30 $12M 19M 0.62

More positions owned by Laurion Capital Management

NVIDIA Corporation Call Option (NVDA)
Advanced Micro Devices Call Option (AMD)
Meta Platforms Cl A Call Option (META)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
United States Steel Corporation (X)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Hess (HES)
Ansys (ANSS)
Discover Financial Services (DFS)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
Broadcom Call Option (AVGO)
Bridgebio Pharma (BBIO)
Bank of America Corporation (BAC)

View all positions for Laurion Capital Management

Top funds holding Bridgebio Pharma

Ing Investment Management
Braidwell
D. E. Shaw & Co
Weiss Asset Management LP[1
Aristeia Capital
MacKay Shields
Nuveen Asset Management
Laurion Capital Management
Advent Capital Management
CNH Partners
State Street Corporation
Sona Asset Management
Wells Fargo & Company
Bank of America Corporation
Calamos Advisors

View all funds holding Bridgebio Pharma